Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Non-invasive prenatal testing for trisomy 21 based on analysis of cell-free fetal DNA circulating in the maternal plasma.

Alberti A, Salomon LJ, Le Lorc'h M, Couloux A, Bussières L, Goupil S, Malan V, Pelletier E, Hyon C, Vialard F, Rozenberg P, Bouhanna P, Oury JF, Schmitz T, Romana S, Weissenbach J, Vekemans M, Ville Y.

Prenat Diagn. 2015 May;35(5):471-6. doi: 10.1002/pd.4561.

PMID:
25643828
2.

Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.

Revello R, Sarno L, Ispas A, Akolekar R, Nicolaides KH.

Ultrasound Obstet Gynecol. 2016 Jun;47(6):698-704. doi: 10.1002/uog.15851. Epub 2016 Apr 25.

3.

[Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].

Wang SJ, Gao ZY, Lu YP, Li YL, You YQ, Zhang LW, Wang LX, Xu H.

Zhonghua Fu Chan Ke Za Zhi. 2012 Nov;47(11):808-12. Chinese.

PMID:
23302119
4.

[Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].

Hou QF, Wu D, Chu Y, Kang B, Liao SX, Yang YL, Zhang CY, Zhang JX, Wu G.

Zhonghua Fu Chan Ke Za Zhi. 2012 Nov;47(11):813-7. Chinese.

PMID:
23302120
5.

Trends in timing of prenatal diagnosis and abortion for fetal chromosomal abnormalities.

Hume H, Chasen ST.

Am J Obstet Gynecol. 2015 Oct;213(4):545.e1-4. doi: 10.1016/j.ajog.2015.06.008. Epub 2015 Jun 10.

PMID:
26070711
6.

Non-invasive prenatal testing for fetal aneuploidies in the first trimester of pregnancy.

Song Y, Huang S, Zhou X, Jiang Y, Qi Q, Bian X, Zhang J, Yan Y, Cram DS, Liu J.

Ultrasound Obstet Gynecol. 2015 Jan;45(1):55-60. doi: 10.1002/uog.13460. Epub 2014 Dec 1.

7.

Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing.

Lau TK, Chen F, Pan X, Pooh RK, Jiang F, Li Y, Jiang H, Li X, Chen S, Zhang X.

J Matern Fetal Neonatal Med. 2012 Aug;25(8):1370-4. doi: 10.3109/14767058.2011.635730. Epub 2012 Feb 24.

PMID:
22070770
8.

A new model for providing cell-free DNA and risk assessment for chromosome abnormalities in a public hospital setting.

Wallerstein R, Jelks A, Garabedian MJ.

J Pregnancy. 2014;2014:962720. doi: 10.1155/2014/962720. Epub 2014 Jul 2.

9.

The triple-marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity.

Huderer-Duric K, Skrablin S, Kuvacic I, Sonicki Z, Rubala D, Suchanek E.

Eur J Obstet Gynecol Reprod Biol. 2000 Jan;88(1):49-55.

PMID:
10659916
10.

Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population.

Nicolaides KH, Syngelaki A, Ashoor G, Birdir C, Touzet G.

Am J Obstet Gynecol. 2012 Nov;207(5):374.e1-6. doi: 10.1016/j.ajog.2012.08.033. Epub 2012 Sep 19.

PMID:
23107079
11.

Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18.

Ashoor G, Syngelaki A, Wagner M, Birdir C, Nicolaides KH.

Am J Obstet Gynecol. 2012 Apr;206(4):322.e1-5. doi: 10.1016/j.ajog.2012.01.029. Epub 2012 Jan 24.

PMID:
22464073
12.

Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study.

Chiu RW, Akolekar R, Zheng YW, Leung TY, Sun H, Chan KC, Lun FM, Go AT, Lau ET, To WW, Leung WC, Tang RY, Au-Yeung SK, Lam H, Kung YY, Zhang X, van Vugt JM, Minekawa R, Tang MH, Wang J, Oudejans CB, Lau TK, Nicolaides KH, Lo YM.

BMJ. 2011 Jan 11;342:c7401. doi: 10.1136/bmj.c7401.

14.

Nearly a third of abnormalities found after first-trimester screening are different than expected: 10-year experience from a single center.

Alamillo CM, Krantz D, Evans M, Fiddler M, Pergament E.

Prenat Diagn. 2013 Mar;33(3):251-6. doi: 10.1002/pd.4054. Epub 2013 Jan 27.

PMID:
23354915
15.

Noninvasive prenatal testing of trisomies 21 and 18 by massively parallel sequencing of maternal plasma DNA in twin pregnancies.

Huang X, Zheng J, Chen M, Zhao Y, Zhang C, Liu L, Xie W, Shi S, Wei Y, Lei D, Xu C, Wu Q, Guo X, Shi X, Zhou Y, Liu Q, Gao Y, Jiang F, Zhang H, Su F, Ge H, Li X, Pan X, Chen S, Chen F, Fang Q, Jiang H, Lau TK, Wang W.

Prenat Diagn. 2014 Apr;34(4):335-40. doi: 10.1002/pd.4303. Epub 2014 Feb 3.

PMID:
24357023
16.

Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies.

Gil MM, Quezada MS, Bregant B, Ferraro M, Nicolaides KH.

Ultrasound Obstet Gynecol. 2013 Jul;42(1):34-40. doi: 10.1002/uog.12504. Epub 2013 Jun 7.

17.

Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities.

Zimmermann R, Hucha A, Savoldelli G, Binkert F, Achermann J, Grudzinskas JG.

Br J Obstet Gynaecol. 1996 Oct;103(10):1009-14.

PMID:
8863700
18.

Prenatal diagnosis versus first-trimester screening of trisomy 21 among pregnant women aged 35 or more.

Ghi T, Arcangeli T, Ravennati F, Salsi G, Montaguti E, Pacella G, Maroni E, Pittalis MC, Pompilii E, Pilu G, Rizzo N.

J Matern Fetal Neonatal Med. 2015 Apr;28(6):674-8. doi: 10.3109/14767058.2014.928852. Epub 2014 Jun 26.

PMID:
24866349
19.

Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method.

Ashoor G, Syngelaki A, Wang E, Struble C, Oliphant A, Song K, Nicolaides KH.

Ultrasound Obstet Gynecol. 2013 Jan;41(1):21-5. doi: 10.1002/uog.12299. Epub 2012 Nov 23.

20.

Supplemental Content

Support Center